Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Cost of RevenueGross ProfitLeasesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsReceivables - OtherRevenue - OtherShares IssuedShares OutstandingShares OutstandingShort-Term Debt repayments
Ratios

InflaRx (IFRX) Cost of Revenue (2023 - 2026)

InflaRx's Cost of Revenue history spans 4 years, with the latest figure at $126524.8 for Q1 2026.

  • On a quarterly basis, Cost of Revenue fell 100.0% to $126524.8 in Q1 2026 year-over-year; TTM through Mar 2026 was $8.6 million, a 99.91% decrease, with the full-year FY2025 number at $8.5 million, up 138.67% from a year prior.
  • Cost of Revenue hit $126524.8 in Q1 2026 for InflaRx, down from $5.7 million in the prior quarter.
  • Over the last five years, Cost of Revenue for IFRX hit a ceiling of $277.7 billion in Q3 2023 and a floor of $79681.3 in Q3 2024.
  • Historically, Cost of Revenue has averaged $24.0 billion across 4 years, with a median of $337760.2 in 2024.
  • Biggest five-year swings in Cost of Revenue: tumbled 100.0% in 2024 and later skyrocketed 4079391.8% in 2025.
  • Tracing IFRX's Cost of Revenue over 4 years: stood at $298192.4 in 2023, then surged by 910.9% to $3.0 million in 2024, then soared by 87.61% to $5.7 million in 2025, then tumbled by 97.76% to $126524.8 in 2026.
  • Business Quant data shows Cost of Revenue for IFRX at $126524.8 in Q1 2026, $5.7 million in Q4 2025, and $85210.1 in Q3 2025.